InHoUDsoPGaVe
WaaRsCHUWInG ........................................................................... 47
ConTRa-InDICaTIes ...................................................................... 48
CoMPlICaTIes................................................................................. 49
leVeRInG .......................................................................................... 50
WaaRsCHUWInG .......................................................................... 50
WaaRsCHUWInG ........................................................................... 52
Afbeelding 5. ......................................................................... 52
Afbeelding 6. ......................................................................... 53
Afbeelding 7. ......................................................................... 53
GaRanTIe ......................................................................................... 54
Black (K) ∆E ≤5.0
46